BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38336268)

  • 1. A homologous-targeting cGAS-STING agonist multimodally activates dendritic cells for enhanced cancer immunotherapy.
    Wang P; Wang Y; Li H; Wang M; Wang Y; Wang X; Ran L; Xin H; Ma J; Tian G; Gao W; Zhang G
    Acta Biomater; 2024 Mar; 177():400-413. PubMed ID: 38336268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese-Based Nanoactivator Optimizes Cancer Immunotherapy
    Hou L; Tian C; Yan Y; Zhang L; Zhang H; Zhang Z
    ACS Nano; 2020 Apr; 14(4):3927-3940. PubMed ID: 32298077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death.
    Guo Y; Qian R; Li Z; Lv T; Yang C; Li W; Pan T; Hou X; Wang Z
    Life Sci; 2024 Jul; 348():122687. PubMed ID: 38718856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outer membrane vesicle-wrapped manganese nanoreactor for augmenting cancer metalloimmunotherapy through hypoxia attenuation and immune stimulation.
    Luo S; Yang Y; Chen L; Kannan PR; Yang W; Zhang Y; Zhao R; Liu X; Li Y; Kong X
    Acta Biomater; 2024 Jun; 181():402-414. PubMed ID: 38734282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically Edited Cascade Nanozymes for Cancer Immunotherapy.
    Zhang J; Pan Y; Liu L; Xu Y; Zhao C; Liu W; Rao L
    ACS Nano; 2024 May; 18(19):12295-12310. PubMed ID: 38695532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A manganese-phenolic network platform amplifying STING activation to potentiate MRI guided cancer chemo-/chemodynamic/immune therapy.
    Pang X; Fu C; Chen J; Su M; Wei R; Wang Y; Lin W; Wei X; Jiang X; Yang X; Yang H; Wang J; Yang R
    Biomater Sci; 2023 May; 11(11):3840-3850. PubMed ID: 37074080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway.
    Cheng L; Zhang P; Liu Y; Liu Z; Tang J; Xu L; Liu J
    Biomaterials; 2023 Oct; 301():122259. PubMed ID: 37531777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal coordination nanotheranostics mediated by nucleoside metabolic inhibitors potentiate STING pathway activation for cancer metalloimmunotherapy.
    Yang L; Wang Y; Song Y; Li Z; Lei L; Li H; He B; Cao J; Gao H
    J Control Release; 2024 May; 370():354-366. PubMed ID: 38685387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of doxorubicin and STING agonist cGAMP for enhanced antitumor immunity.
    Xie Y; Li K; Liang J; Wang K; Gong Z; Chen X
    Int J Pharm; 2024 Apr; 654():123955. PubMed ID: 38423155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential reinforcement of cGAS-STING pathway-involved immunotherapy by biomineralized bacterial outer membrane-sensitized EBRT and RNT.
    Shen M; Guo L; Zhang H; Zheng B; Liu X; Gu J; Yang T; Sun C; Yi X
    J Nanobiotechnology; 2024 Jun; 22(1):310. PubMed ID: 38831378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomineralized MnO
    Deng Z; Xi M; Zhang C; Wu X; Li Q; Wang C; Fang H; Sun G; Zhang Y; Yang G; Liu Z
    ACS Nano; 2023 Mar; 17(5):4495-4506. PubMed ID: 36848115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy.
    Cao L; Tian H; Fang M; Xu Z; Tang D; Chen J; Yin J; Xiao H; Shang K; Han H; Li X
    Biomaterials; 2022 Nov; 290():121856. PubMed ID: 36306685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAIL-modified, doxorubicin-embedded periodic mesoporous organosilica nanoparticles for targeted drug delivery and efficient antitumor immunotherapy.
    Feng X; Li F; Zhang L; Liu W; Wang X; Zhu R; Qiao ZA; Yu B; Yu X
    Acta Biomater; 2022 Apr; 143():392-405. PubMed ID: 35259519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smart responsive Fe/Mn nanovaccine triggers liver cancer immunotherapy via pyroptosis and pyroptosis-boosted cGAS-STING activation.
    Du Q; Luo Y; Xu L; Du C; Zhang W; Xu J; Liu Y; Liu B; Chen S; Wang Y; Wang Z; Ran H; Wang J; Guo D
    J Nanobiotechnology; 2024 Mar; 22(1):95. PubMed ID: 38448959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers.
    Yi M; Niu M; Zhang J; Li S; Zhu S; Yan Y; Li N; Zhou P; Chu Q; Wu K
    J Hematol Oncol; 2021 Sep; 14(1):146. PubMed ID: 34526097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic expression of cGAS in
    Waanders L; van der Donk LEH; Ates LS; Maaskant J; van Hamme JL; Eldering E; van Bruggen JAC; Rietveld JM; Bitter W; Geijtenbeek TBH; Kuijl CP
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoscale Metal-Organic Frameworks-Mediated Degradation of Mutant p53 Proteins and Activation of cGAS-STING Pathway for Enhanced Cancer Immunotherapy.
    Sun L; Gao H; Wang H; Zhou J; Ji X; Jiao Y; Qin X; Ni D; Zheng X
    Adv Sci (Weinh); 2024 Mar; 11(12):e2307278. PubMed ID: 38225693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplifying STING activation by bioinspired nanomedicine for targeted chemo- and immunotherapy of acute myeloid leukemia.
    Wang X; Huang R; Wu W; Xiong J; Wen Q; Zeng Y; Chen T; Li J; Zhang C; Zhong JF; Yang S; Zhang X
    Acta Biomater; 2023 Feb; 157():381-394. PubMed ID: 36375786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional Calcium-Manganese Nanomodulator Provides Antitumor Treatment and Improved Immunotherapy via Reprogramming of the Tumor Microenvironment.
    Luo G; Li X; Lin J; Ge G; Fang J; Song W; Xiao GG; Zhang B; Peng X; Duo Y; Tang BZ
    ACS Nano; 2023 Aug; 17(16):15449-15465. PubMed ID: 37530575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.